 Shawn O'Neil
Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simian Acquired Immunodeficiency Syndrome | 26 | 2013 | 98 | 3.080 |
Why?
| | Simian Immunodeficiency Virus | 24 | 2013 | 98 | 3.010 |
Why?
| | Macaca mulatta | 17 | 2011 | 153 | 1.410 |
Why?
| | Viral Load | 11 | 2013 | 419 | 0.660 |
Why?
| | Cercocebus atys | 6 | 2013 | 12 | 0.640 |
Why?
| | Germinal Center | 1 | 2013 | 47 | 0.450 |
Why?
| | CD8-Positive T-Lymphocytes | 5 | 2011 | 702 | 0.420 |
Why?
| | CD8 Antigens | 1 | 2010 | 71 | 0.390 |
Why?
| | Macaca nemestrina | 7 | 2008 | 34 | 0.380 |
Why?
| | Lymph Nodes | 9 | 2013 | 455 | 0.380 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2010 | 81 | 0.380 |
Why?
| | Myocarditis | 1 | 2010 | 95 | 0.350 |
Why?
| | Interleukin-18 | 1 | 2010 | 229 | 0.340 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2010 | 369 | 0.330 |
Why?
| | Lectins, C-Type | 1 | 2008 | 63 | 0.330 |
Why?
| | Anti-Retroviral Agents | 1 | 2010 | 208 | 0.320 |
Why?
| | Brain | 4 | 2011 | 2490 | 0.320 |
Why?
| | Cell Adhesion Molecules | 1 | 2008 | 180 | 0.300 |
Why?
| | Monkey Diseases | 2 | 2011 | 21 | 0.280 |
Why?
| | Receptors, Cell Surface | 1 | 2008 | 367 | 0.280 |
Why?
| | Down-Regulation | 1 | 2008 | 627 | 0.270 |
Why?
| | Tritrichomonas | 1 | 2005 | 1 | 0.260 |
Why?
| | Protozoan Infections | 1 | 2005 | 11 | 0.260 |
Why?
| | Encephalitis, Viral | 2 | 2011 | 44 | 0.260 |
Why?
| | Protozoan Infections, Animal | 1 | 2005 | 4 | 0.260 |
Why?
| | Gastritis | 1 | 2005 | 82 | 0.240 |
Why?
| | Animals | 32 | 2013 | 33399 | 0.230 |
Why?
| | Immunohistochemistry | 6 | 2011 | 1691 | 0.210 |
Why?
| | Molecular Sequence Data | 10 | 2010 | 2873 | 0.200 |
Why?
| | In Situ Hybridization | 5 | 2011 | 311 | 0.190 |
Why?
| | Gene Products, env | 5 | 2009 | 13 | 0.190 |
Why?
| | CD4-Positive T-Lymphocytes | 5 | 2013 | 985 | 0.180 |
Why?
| | Lymphoid Tissue | 3 | 2010 | 65 | 0.180 |
Why?
| | HIV-1 | 4 | 2010 | 776 | 0.170 |
Why?
| | Base Sequence | 6 | 2010 | 2160 | 0.170 |
Why?
| | AIDS Vaccines | 3 | 2003 | 44 | 0.160 |
Why?
| | Macaca | 3 | 2013 | 54 | 0.160 |
Why?
| | Macrophages | 5 | 2010 | 1324 | 0.160 |
Why?
| | Acquired Immunodeficiency Syndrome | 3 | 2008 | 224 | 0.150 |
Why?
| | RNA, Viral | 4 | 2013 | 572 | 0.150 |
Why?
| | Antiretroviral Therapy, Highly Active | 2 | 2010 | 260 | 0.150 |
Why?
| | Viral Envelope Proteins | 3 | 2008 | 80 | 0.140 |
Why?
| | Virus Replication | 4 | 2010 | 405 | 0.140 |
Why?
| | Spleen | 3 | 2010 | 510 | 0.140 |
Why?
| | Polymerase Chain Reaction | 4 | 2005 | 1012 | 0.120 |
Why?
| | Organ Specificity | 3 | 2008 | 278 | 0.120 |
Why?
| | Ehrlichiosis | 1 | 1994 | 4 | 0.120 |
Why?
| | Cat Diseases | 1 | 1994 | 15 | 0.120 |
Why?
| | Vaccines, DNA | 3 | 2003 | 32 | 0.120 |
Why?
| | T-Lymphocyte Subsets | 3 | 2008 | 396 | 0.120 |
Why?
| | Fusion Proteins, gag-pol | 2 | 2003 | 4 | 0.110 |
Why?
| | Lymphocyte Depletion | 2 | 2011 | 119 | 0.110 |
Why?
| | Immunophenotyping | 1 | 2013 | 278 | 0.110 |
Why?
| | Gene Products, gag | 2 | 2010 | 38 | 0.100 |
Why?
| | Amino Acid Sequence | 4 | 2010 | 2073 | 0.100 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2011 | 508 | 0.100 |
Why?
| | HIV Envelope Protein gp120 | 3 | 2003 | 60 | 0.100 |
Why?
| | Morphine Dependence | 1 | 2010 | 4 | 0.100 |
Why?
| | Nucleosides | 1 | 2010 | 26 | 0.100 |
Why?
| | Sequence Analysis, Protein | 1 | 2010 | 31 | 0.100 |
Why?
| | Proviruses | 3 | 1999 | 9 | 0.090 |
Why?
| | Lymphatic Diseases | 1 | 2010 | 18 | 0.090 |
Why?
| | Vaccinia virus | 4 | 2003 | 34 | 0.090 |
Why?
| | Cloning, Molecular | 2 | 2010 | 546 | 0.090 |
Why?
| | Brain Chemistry | 1 | 2010 | 119 | 0.090 |
Why?
| | SAIDS Vaccines | 2 | 2003 | 5 | 0.090 |
Why?
| | Nucleotides | 1 | 2010 | 112 | 0.090 |
Why?
| | Molecular Weight | 1 | 2010 | 343 | 0.090 |
Why?
| | Acute Disease | 1 | 2013 | 941 | 0.090 |
Why?
| | Mucous Membrane | 1 | 2010 | 113 | 0.090 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 286 | 0.090 |
Why?
| | Lymphocytes | 1 | 2010 | 347 | 0.080 |
Why?
| | Protein Transport | 1 | 2010 | 412 | 0.080 |
Why?
| | Central Nervous System | 2 | 2009 | 245 | 0.080 |
Why?
| | Mesentery | 1 | 2008 | 56 | 0.080 |
Why?
| | Gastrointestinal Diseases | 1 | 2010 | 187 | 0.080 |
Why?
| | CD4 Lymphocyte Count | 6 | 2010 | 267 | 0.080 |
Why?
| | Lymphocyte Activation | 3 | 2008 | 1067 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 653 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 404 | 0.080 |
Why?
| | Viremia | 5 | 2011 | 132 | 0.080 |
Why?
| | Disease Progression | 3 | 2010 | 2490 | 0.080 |
Why?
| | Interferon-gamma | 1 | 2010 | 737 | 0.070 |
Why?
| | Lipopolysaccharides | 1 | 2010 | 870 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2010 | 346 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2011 | 1085 | 0.070 |
Why?
| | Immunoglobulin G | 1 | 2010 | 788 | 0.070 |
Why?
| | Neuroimmunomodulation | 1 | 2006 | 72 | 0.070 |
Why?
| | Genes, nef | 2 | 2003 | 2 | 0.070 |
Why?
| | Myocardium | 1 | 2010 | 970 | 0.070 |
Why?
| | RNA, Ribosomal, 5.8S | 1 | 2005 | 2 | 0.070 |
Why?
| | DNA, Protozoan | 1 | 2005 | 28 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1175 | 0.060 |
Why?
| | RNA, Protozoan | 1 | 2005 | 58 | 0.060 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2005 | 140 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 811 | 0.060 |
Why?
| | Genetic Variation | 1 | 2009 | 926 | 0.060 |
Why?
| | Membrane Glycoproteins | 2 | 1996 | 446 | 0.050 |
Why?
| | Antibody Formation | 1 | 2004 | 276 | 0.050 |
Why?
| | Viral Proteins | 2 | 2009 | 296 | 0.050 |
Why?
| | Intestinal Mucosa | 2 | 2010 | 531 | 0.050 |
Why?
| | Opioid-Related Disorders | 1 | 2009 | 417 | 0.050 |
Why?
| | Antibodies, Viral | 4 | 1999 | 542 | 0.050 |
Why?
| | Vaccines, Synthetic | 3 | 2002 | 128 | 0.050 |
Why?
| | Apoptosis | 2 | 2008 | 2484 | 0.050 |
Why?
| | Pan troglodytes | 2 | 2001 | 57 | 0.050 |
Why?
| | Female | 9 | 2010 | 61588 | 0.050 |
Why?
| | B-Lymphocytes | 2 | 2010 | 770 | 0.050 |
Why?
| | Tropism | 1 | 1999 | 2 | 0.040 |
Why?
| | Retroviridae Proteins | 1 | 1999 | 12 | 0.040 |
Why?
| | Groin | 1 | 1999 | 17 | 0.040 |
Why?
| | Axilla | 1 | 1999 | 57 | 0.040 |
Why?
| | Antibody Specificity | 1 | 1999 | 184 | 0.040 |
Why?
| | Central Nervous System Infections | 1 | 1998 | 39 | 0.040 |
Why?
| | Mice | 3 | 2010 | 15528 | 0.040 |
Why?
| | Thymus Gland | 1 | 1999 | 300 | 0.040 |
Why?
| | Male | 6 | 2010 | 57818 | 0.040 |
Why?
| | Retrospective Studies | 2 | 2005 | 12990 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 827 | 0.040 |
Why?
| | Semliki forest virus | 1 | 1996 | 2 | 0.040 |
Why?
| | Pyoderma | 1 | 1995 | 3 | 0.030 |
Why?
| | Paraproteinemias | 1 | 1995 | 5 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 2 | 1998 | 509 | 0.030 |
Why?
| | Intestines | 1 | 1999 | 332 | 0.030 |
Why?
| | Rectum | 2 | 2010 | 157 | 0.030 |
Why?
| | Humans | 10 | 2010 | 119032 | 0.030 |
Why?
| | Dog Diseases | 1 | 1995 | 44 | 0.030 |
Why?
| | Vaccination | 3 | 2002 | 1223 | 0.030 |
Why?
| | Ehrlichia | 1 | 1994 | 2 | 0.030 |
Why?
| | Immunotherapy, Active | 1 | 1994 | 9 | 0.030 |
Why?
| | Macaca fascicularis | 2 | 2010 | 53 | 0.030 |
Why?
| | Doxycycline | 1 | 1994 | 60 | 0.030 |
Why?
| | Cats | 1 | 1994 | 205 | 0.030 |
Why?
| | Dogs | 2 | 2010 | 371 | 0.030 |
Why?
| | Antibodies, Bacterial | 1 | 1994 | 126 | 0.030 |
Why?
| | Viral Vaccines | 1 | 1994 | 90 | 0.030 |
Why?
| | HIV Infections | 2 | 2010 | 2461 | 0.030 |
Why?
| | Time Factors | 2 | 2003 | 6414 | 0.030 |
Why?
| | Virulence | 2 | 2003 | 240 | 0.030 |
Why?
| | Synaptophysin | 1 | 2011 | 12 | 0.030 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2011 | 87 | 0.020 |
Why?
| | Protons | 1 | 2011 | 79 | 0.020 |
Why?
| | Inositol | 1 | 2010 | 26 | 0.020 |
Why?
| | Toxicity Tests, Acute | 1 | 2010 | 10 | 0.020 |
Why?
| | Creatine | 1 | 2010 | 56 | 0.020 |
Why?
| | Aspartic Acid | 1 | 2010 | 86 | 0.020 |
Why?
| | Narcotics | 1 | 2010 | 50 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2011 | 134 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 296 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2010 | 82 | 0.020 |
Why?
| | Cells, Cultured | 3 | 2010 | 4081 | 0.020 |
Why?
| | Microtubule-Associated Proteins | 1 | 2011 | 188 | 0.020 |
Why?
| | Morphine | 1 | 2010 | 134 | 0.020 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2009 | 28 | 0.020 |
Why?
| | Astrocytes | 1 | 2011 | 177 | 0.020 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2010 | 109 | 0.020 |
Why?
| | Serial Passage | 1 | 2008 | 2 | 0.020 |
Why?
| | Microglia | 1 | 2011 | 221 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2010 | 224 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2009 | 135 | 0.020 |
Why?
| | Immunization, Secondary | 2 | 2002 | 85 | 0.020 |
Why?
| | Vagina | 1 | 2010 | 151 | 0.020 |
Why?
| | Integrases | 1 | 2009 | 123 | 0.020 |
Why?
| | Colon | 1 | 2010 | 238 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2010 | 331 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2008 | 336 | 0.020 |
Why?
| | Cell Line | 2 | 2008 | 2707 | 0.020 |
Why?
| | Immunity, Cellular | 2 | 2002 | 270 | 0.020 |
Why?
| | Linear Models | 1 | 2010 | 827 | 0.020 |
Why?
| | Blotting, Western | 1 | 2010 | 1195 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2011 | 3730 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2009 | 755 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2009 | 642 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2478 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2011 | 1285 | 0.020 |
Why?
| | Chronic Disease | 2 | 2003 | 1637 | 0.010 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2003 | 12 | 0.010 |
Why?
| | Viral Fusion Proteins | 1 | 2003 | 20 | 0.010 |
Why?
| | Neurons | 1 | 2011 | 1345 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2010 | 2275 | 0.010 |
Why?
| | Vaccines, Attenuated | 1 | 2003 | 114 | 0.010 |
Why?
| | DNA, Viral | 2 | 1996 | 356 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1774 | 0.010 |
Why?
| | HIV Antibodies | 1 | 2002 | 50 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2009 | 2513 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2002 | 180 | 0.010 |
Why?
| | Bone Marrow | 1 | 2003 | 255 | 0.010 |
Why?
| | Rats | 1 | 2010 | 5394 | 0.010 |
Why?
| | Immunity, Mucosal | 1 | 2002 | 86 | 0.010 |
Why?
| | Gene Deletion | 1 | 2003 | 361 | 0.010 |
Why?
| | HIV | 1 | 2002 | 210 | 0.010 |
Why?
| | Immunization Schedule | 1 | 2002 | 188 | 0.010 |
Why?
| | Cytokines | 1 | 2008 | 1900 | 0.010 |
Why?
| | Immunologic Memory | 1 | 2002 | 313 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 975 | 0.010 |
Why?
| | Inflammation | 1 | 2010 | 2571 | 0.010 |
Why?
| | Simian T-lymphotropic virus 1 | 1 | 1998 | 1 | 0.010 |
Why?
| | Deltaretrovirus Infections | 1 | 1998 | 7 | 0.010 |
Why?
| | Genes, env | 1 | 1998 | 5 | 0.010 |
Why?
| | AIDS Dementia Complex | 1 | 1998 | 52 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1998 | 372 | 0.010 |
Why?
| | Blood Transfusion | 1 | 1998 | 306 | 0.010 |
Why?
| | Cricetinae | 1 | 1996 | 263 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1996 | 302 | 0.010 |
Why?
| | Prognosis | 1 | 2003 | 3443 | 0.010 |
Why?
| | Neutralization Tests | 1 | 1994 | 66 | 0.010 |
Why?
| | Blood | 1 | 1994 | 100 | 0.010 |
Why?
| | Cell-Free System | 1 | 1993 | 49 | 0.010 |
Why?
| | Digestive System | 1 | 1993 | 30 | 0.010 |
Why?
| | Lymphocyte Subsets | 1 | 1993 | 76 | 0.010 |
Why?
| | Saliva | 1 | 1993 | 188 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1994 | 1308 | 0.010 |
Why?
|
|
O'Neil's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|